CooperVision sponsors Optometry Giving Sight, gets FDA OK for Avaira toric CLs

Article

The Food and Drug Administration has granted a Special 510(k) clearance for CooperVision's Avaira Toric 2-week silicone hydrogel contact lenses for astigmatism. The lenses are available for select distribution beginning this month.

Pleasanton, CA-The Food and Drug Administration has granted a Special 510(k) clearance for CooperVision's Avaira Toric 2-week silicone hydrogel contact lenses for astigmatism. The lenses are available for select distribution beginning this month.

The company also has made a 2-year commitment to support Optometry Giving Sight as a Platinum Gold Sponsor. The World Council of Optometry, the International Centre created Optometry Giving Sight in 2003 for Eyecare Education and the International Agency for the Prevention of Blindness to mobilize resources from the global optometric community to fund sustainable vision care in underserved areas.

“This is a very significant commitment by our company to an organization that we believe is having a substantial impact on the delivery of sustainable eye care services in underserved communities throughout the world,” CooperVision President John Weber said. “As a global company, we think it makes absolute sense to actively support a global charity, especially one that is doing so much to promote and develop optometry as a respected and recognized profession throughout the world.”

For more articles in this issue of InDispensable, click here.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.